Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tiihonen AM"'
Autor:
Kiviaho A; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Eerola SK; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Kallio HML; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Andersen MK; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.; Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Hoikka M; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Tiihonen AM; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Salonen I; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Spotbeen X; Laboratory of Lipid Metabolism and Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.; KU Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium., Giesen A; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium., Parker CTA; University College London Cancer Institute, London, UK., Taavitsainen S; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Hantula O; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Marttinen M; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland.; European Molecular Biology Laboratory, Structural and Computational Biology Unit, Heidelberg, Germany.; European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany., Hermelo I; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Ismail M; University College London Cancer Institute, London, UK., Midtbust E; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.; Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Wess M; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.; Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Devlies W; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Molecular Endocrinology Laboratory, Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Sharma A; Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Krossa S; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.; Central staff, St. Olavs Hospital HF, 7006, Trondheim, Norway., Häkkinen T; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Afyounian E; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Vandereyken K; KU Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.; Laboratory of Reproductive Genomics, Department of Human Genetics, KU Leuven, Leuven, Belgium., Kint S; KU Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.; Laboratory of Reproductive Genomics, Department of Human Genetics, KU Leuven, Leuven, Belgium., Kesseli J; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Tolonen T; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland.; Department of Pathology, Fimlab Laboratories, Ltd, Tampere University Hospital, Tampere, Finland., Tammela TLJ; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Urology, Tampere University Hospital, Tampere, Finland., Viset T; Department of Pathology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Størkersen Ø; Department of Pathology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Giskeødegård GF; Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Rye MB; Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Murtola T; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Erickson A; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; ICAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Latonen L; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland., Bova GS; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Mills IG; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.; Patrick G Johnston Centre for Cancer Research, Queen's University of Belfast, Belfast, UK., Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium., Swinnen JV; Laboratory of Lipid Metabolism and Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.; KU Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium., Voet T; KU Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.; Laboratory of Reproductive Genomics, Department of Human Genetics, KU Leuven, Leuven, Belgium., Mirtti T; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; ICAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Department of Pathology, University of Helsinki & Helsinki University Hospital, Helsinki, Finland., Attard G; University College London Cancer Institute, London, UK.; University College London Hospitals, London, UK., Claessens F; Molecular Endocrinology Laboratory, Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Visakorpi T; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland.; Fimlab Laboratories, Ltd, Tampere University Hospital, Tampere, Finland., Rautajoki KJ; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland., Tessem MB; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.; Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Urbanucci A; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. alfonso.urbanucci@tuni.fi.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland. alfonso.urbanucci@tuni.fi.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. alfonso.urbanucci@tuni.fi., Nykter M; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. matti.nykter@tuni.fi.; Prostate Cancer Research Center, Tampere University and TAYS Cancer Center, Tampere, Finland. matti.nykter@tuni.fi.
Publikováno v:
Nature communications [Nat Commun] 2024 Nov 16; Vol. 15 (1), pp. 9949. Date of Electronic Publication: 2024 Nov 16.
Autor:
Governa V; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., de Oliveira KG; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Bång-Rudenstam A; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Offer S; Joint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics, Helmholtz Zentrum München, Neuherberg 85764, Germany., Cerezo-Magaña M; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Li J; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Beyer S; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Johansson MC; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Månsson AS; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Edvardsson C; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Durmo F; Division of Diagnostic Radiology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Gustafsson E; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Boukredine A; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Jeannot P; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund, Lund University, Lund 221 00, Sweden., Schmidt K; Infectious Diseases and Immunodeficiency Section, Department of Medicine 3, University Hospital Erlangen, Friedrich-Alexander-University Erlangen, Erlangen 91054, Germany., Gezelius E; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Menard JA; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Garza R; Laboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund 221 00, Sweden., Jakobsson J; Laboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund 221 00, Sweden., de Neergaard T; Division of Infection Medicine, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Sundgren PC; Division of Diagnostic Radiology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden.; Lund Bioimaging Centre, Lund University, Lund 221 00, Sweden.; Department of Medical Imaging and Function, Skåne University Hospital, Lund 221 85, Sweden., Tiihonen AM; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere 33101, Finland., Haapasalo H; Fimlab Laboratories Ltd., Tampere University Hospital, Tampere 33101, Finland., Rautajoki KJ; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere 33101, Finland., Nordenfelt P; Division of Infection Medicine, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Darabi A; Division of Neurosurgery, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Forsberg-Nilsson K; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala 751 85, Sweden.; Biodiscovery Institute, University of Nottingham, Nottingham NG7 2QL, UK.; Science for Life Laboratory, Uppsala 752 37, Sweden., Pietras A; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund, Lund University, Lund 221 00, Sweden., Talbot H; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden., Bengzon J; Division of Neurosurgery, Department of Clinical Sciences, Lund, Lund University Hospital, Lund 221 85, Sweden., Belting M; Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund 221 00, Sweden.; Department of Hematology, Oncology and Radiophysics, Skåne University Hospital, Lund 221 85, Sweden.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Oct 30; Vol. 16 (771), pp. eadk1168. Date of Electronic Publication: 2024 Oct 30.
Autor:
Rautajoki KJ; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland. kirsi.rautajoki@tuni.fi.; Tampere Institute for Advanced Study, Tampere University, Tampere, Finland. kirsi.rautajoki@tuni.fi., Jaatinen S; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland., Hartewig A; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland., Tiihonen AM; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland., Annala M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland., Salonen I; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland., Valkonen M; Institute of Biomedicine, University of Turku, Turku, Finland., Simola V; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland., Vuorinen EM; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland., Kivinen A; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland., Rauhala MJ; Department of Neurosurgery, Tampere University Hospital and Tampere University, Tampere, Finland.; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland., Nurminen R; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland., Maass KK; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro Oncology, German Cancer Research Center, German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany., Lahtela SL; Department of Oncology, Tampere University Hospital and Tays Cancer Centre, Tampere, Finland., Jukkola A; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Department of Oncology, Tampere University Hospital and Tays Cancer Centre, Tampere, Finland., Yli-Harja O; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Institute for Systems Biology, Seattle, WA, USA., Helén P; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland., Pajtler KW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro Oncology, German Cancer Research Center, German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany., Ruusuvuori P; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland., Haapasalo J; Department of Neurosurgery, Tampere University Hospital and Tampere University, Tampere, Finland.; Fimlab Laboratories Ltd., Tampere University Hospital, Tampere, Finland., Zhang W; Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Haapasalo H; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Fimlab Laboratories Ltd., Tampere University Hospital, Tampere, Finland., Nykter M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Publikováno v:
Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Nov 06; Vol. 11 (1), pp. 176. Date of Electronic Publication: 2023 Nov 06.
Autor:
Rautajoki KJ; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland. kirsi.rautajoki@tuni.fi.; Tampere Institute for Advanced Study, Tampere University, Tampere, Finland. kirsi.rautajoki@tuni.fi., Jaatinen S; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland., Tiihonen AM; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland., Annala M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland., Vuorinen EM; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland., Kivinen A; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland., Rauhala MJ; Department of Neurosurgery, Tampere University Hospital, Tampere, Finland.; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland., Maass KK; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro Oncology, German Cancer Consortium (DKTK), German Cancer Research Center, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany., Pajtler KW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro Oncology, German Cancer Consortium (DKTK), German Cancer Research Center, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany., Yli-Harja O; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Institute for Systems Biology, Seattle, WA, USA., Helén P; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland., Haapasalo J; Department of Neurosurgery, Tampere University Hospital, Tampere, Finland., Haapasalo H; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Fimlab Laboratories Ltd., Tampere University Hospital, Tampere, Finland., Zhang W; Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Nykter M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.; Foundation for the Finnish Cancer Institute, Helsinki, Finland.
Publikováno v:
Scientific reports [Sci Rep] 2022 Aug 18; Vol. 12 (1), pp. 14083. Date of Electronic Publication: 2022 Aug 18.
Autor:
Granberg KJ; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. kirsi.granberg@gmail.com.; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.; Science Center, Tampere University Hospital, Tampere, Finland., Raita A; Fimlab Laboratories Ltd., Tampere University Hospital, Tampere, Finland.; Department of Pathology, Tampere University, Tampere, Finland., Lehtinen B; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.; BioMediTech Institute and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Tiihonen AM; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.; BioMediTech Institute and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Kesseli J; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.; BioMediTech Institute and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Annala M; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.; BioMediTech Institute and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Rodriguez-Martinez A; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.; BioMediTech Institute and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Nordfors K; Department of Pediatrics, Tampere University Hospital, Tampere, Finland.; Tampere Center for Child Health Research, Tampere University, Tampere, Finland., Zhang W; Department of Cancer Biology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, Winston-Salem, NC USA., Visakorpi T; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.; Fimlab Laboratories Ltd., Tampere University Hospital, Tampere, Finland.; BioMediTech Institute and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Nykter M; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.; Science Center, Tampere University Hospital, Tampere, Finland.; BioMediTech Institute and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Haapasalo H; Fimlab Laboratories Ltd., Tampere University Hospital, Tampere, Finland.; Department of Pathology, Tampere University, Tampere, Finland.
Publikováno v:
Histology and histopathology [Histol Histopathol] 2020 Jul; Vol. 35 (7), pp. 673-680. Date of Electronic Publication: 2019 Oct 29.